Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $2.4600 (1.44%) ($2.4600 - $2.4600) on Mon. Apr. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.97% (three month average) | RSI | 20 | Latest Price | $2.4600(1.44%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.8% a day on average for past five trading days. | Weekly Trend | CGEN declines -11.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) IWF(98%) VUG(98%) XLI(98%) EWI(97%) IWO(97%) | Factors Impacting CGEN price | CGEN will decline at least -1.985% in a week (0% probabilities). TLT(-70%) TIP(-12%) SHY(-8%) UUP(-0%) USO(7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.985% (StdDev 3.97%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-19.15(-878.46%) | Resistance Level | $2.88 | 5 Day Moving Average | $2.48(-0.81%) | 10 Day Moving Average | $2.58(-4.65%) | 20 Day Moving Average | $2.88(-14.58%) | To recent high | -31.6% | To recent low | 2.3% | Market Cap | $203m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |